Cart summary

You have no items in your shopping cart.

Navicixizumab

SKU: orb1980573

Description

Navicixizumab (OMP-305B83) is a bispecific anti-VEGF and anti-DLL4 inhibitory antibody that can be combined with Paclitaxel for cancer research, particularly in studies of ovarian, primary peritoneal, or fallopian tube cancer [1] [2] [3].

Images & Validation

Key Properties

TargetNavicixizumab
Purity98.00%
ConjugationUnconjugated

Storage & Handling

StorageMaintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
DisclaimerFor research use only

Similar Products

  • Anti-DLL4 Reference Antibody (navicixizumab) [orb1806225]

    ELISA,  FA,  FACS,  Kinetics

    Human

    Monoclonal

    Unconjugated

    50 μg, 100 μg, 1 mg, 5 mg
  • Anti-DLL4 Reference Antibody (navicixizumab) [orb1818447]

    ELISA,  FC

    Human, Monkey

    Monoclonal

    Unconjugated

    100 μg
  • Navicixizumab (DLL4/VEGFA) - Research Grade Biosimilar [orb1237511]

    Recombinant

    Unconjugated

    0.1 mg
  • Navicixizumab [orb2703343]

    Unconjugated

    100 mg
  • Navicixizumab [orb1140914]

    Unconjugated

    5 mg, 1 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Navicixizumab (orb1980573)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet